1.Xuan Jiang, Manli Wang, Guoliang Cui, Yuanyuan Wu, Zhonghong Wei, Suyun Yu, Aiyun Wang, Wei Zou, Yanhong Pan, Xiaoman Li^*, Yin Lu^*. Tetramethylpyrazine attenuates the cancer stem cell like-properties and doxorubicin resistance by targeting HMGCR in breast cancer, Phytomedicine, 2025, 136: 156344-156358. (共同通讯，中科院一区，IF 8.3)

2.Qi Jia, Yinyin Zhou, Li Song, Ximeng Shi, Xuan Jiang, Ruizhi Tao, Aiyun Wang, YuanyuanWu, Zhonghong Wei, Yinan Zhang^*, Xiaoman Li^*, Yin Lu^*. Baicalin alleviates chronic stress-induced breast cancer metastasis via directly targeting β2-adrenergic receptor, Journal of Pharmaceutical Analysis, 2024, 14(7): 100934-100949. (共同通讯，中科院一区，IF 8.9)

3.Guoliang Cui, Manli Wang, Xiaofeng Li, Can Wang, Kinyu Shon, Zhiting Liu, Lang Ren, Xiaoxian Yang, Xiaoman Li*, Yuanyuan Wu*, Zhiguang Sun^*.Berberine in combination with evodiamine ameliorates gastroesophageal reflux disease through TAS2R38/TRPV1-mediated regulation of MAPK/NF-κB signaling pathways and macrophage polarization.Phytomedicine, 2024, 135: 156251-156267. (共同通讯，中科院一区，IF 8.3)

4.Yichen Liu, Ying Chen, Qiong Zhao, Tianyuan Xie, Chenxi Xiang, Qianqian Guo, Wenzhou Zhang, Yi Zhou, Yin Yuan, Yuxin Zhang, Tao Xi, Xiaoman Li^*, Lufeng Zheng^*. A positive TGF‐β/miR‐9 regulatory loop promotes the expansion and activity of tumour‐initiating cells in breast cancer, British Journal of Pharmacology, 2023, 180(17): 2280-2297.  (共同通讯，中科院二区，IF 7.7)

5.Xiaoman Li^*, Qi Jia^*, Yinyin Zhou, Xuan Jiang, Li Song, Yuanyuan Wu, Aiyun Wang, WenxingChen, Shijun Wang, Yin Lu. Tanshinone IIA attenuates the stemness of breast cancer cells viatargeting the miR-125b/STARD13 axis, Experimental Hematology & Oncology, 2022, 11(1): 2-17. (共同一作，中科院一区，IF 13.5 )

6.Yue Yang^*, Xiaoman Li^*, Ting Wang, Qianqian Guo, Tao Xi, Lufeng Zheng. Emerging agentsthat target signaling pathways in cancer stem cells, Journal of Hematology & Oncology, 2020,13(1): 60-77. (共同一作，中科院一区，IF 40.4)

1.国家自然科学基金委员会，面上项目，82574740，基于“NETs-BCSCs环路”探究小柴胡汤抑制乳腺癌“因郁致转移”的整合调控机制，主持，2026-01-01 至 2029-12-31，49万元，在研

2.国家自然科学基金委员会, 青年科学基金项目（C类）[原青年科学基金项目], 81903857, 丹参酮类成分通过抑制miR-9/STARD13信号轴削弱乳腺癌干细胞样特性及化疗耐药的机制研究, 主持，2020-01-01 至 2022-12-31, 20万元, 结题

3.江苏省高等学校基础科学（自然科学）研究重大项目，24KJA360005，柴胡-黄芩药对协同抗慢性应激诱导的乳腺癌转移研究，主持，2024.7至 2027.7，30万元，在研

4.江苏省中医药科技发展计划项目面上项目，MS2024009，柴胡-黄芩药对干预GR和B2-AR协同抑制慢性应激诱导的乳腺癌转移的作用及机制研究，主持，2025.1至 2027.12，10万元，在研

5.横向课题：中药香薰治疗失眠的药效研究，主持，2025.7-2026.7，22万元，在研

1.Xuan Jiang, Manli Wang, Guoliang Cui, Yuanyuan Wu, Zhonghong Wei, Suyun Yu, Aiyun Wang, Wei Zou, Yanhong Pan, Xiaoman Li^*, Yin Lu^*. Tetramethylpyrazine attenuates the cancer stem cell like-properties and doxorubicin resistance by targeting HMGCR in breast cancer, Phytomedicine, 2025, 136: 156344-156358. (共同通讯，中科院一区，IF 8.3)

2.Qi Jia, Yinyin Zhou, Li Song, Ximeng Shi, Xuan Jiang, Ruizhi Tao, Aiyun Wang, YuanyuanWu, Zhonghong Wei, Yinan Zhang^*, Xiaoman Li^*, Yin Lu^*. Baicalin alleviates chronic stress-induced breast cancer metastasis via directly targeting β2-adrenergic receptor, Journal of Pharmaceutical Analysis, 2024, 14(7): 100934-100949. (共同通讯，中科院一区，IF 8.9)

3.Guoliang Cui, Manli Wang, Xiaofeng Li, Can Wang, Kinyu Shon, Zhiting Liu, Lang Ren, Xiaoxian Yang, Xiaoman Li*, Yuanyuan Wu*, Zhiguang Sun^*.Berberine in combination with evodiamine ameliorates gastroesophageal reflux disease through TAS2R38/TRPV1-mediated regulation of MAPK/NF-κB signaling pathways and macrophage polarization.Phytomedicine, 2024, 135: 156251-156267. (共同通讯，中科院一区，IF 8.3)

4.Yichen Liu, Ying Chen, Qiong Zhao, Tianyuan Xie, Chenxi Xiang, Qianqian Guo, Wenzhou Zhang, Yi Zhou, Yin Yuan, Yuxin Zhang, Tao Xi, Xiaoman Li^*, Lufeng Zheng^*. A positive TGF‐β/miR‐9 regulatory loop promotes the expansion and activity of tumour‐initiating cells in breast cancer, British Journal of Pharmacology, 2023, 180(17): 2280-2297.  (共同通讯，中科院二区，IF 7.7)

5.Xiaoman Li^*, Qi Jia^*, Yinyin Zhou, Xuan Jiang, Li Song, Yuanyuan Wu, Aiyun Wang, WenxingChen, Shijun Wang, Yin Lu. Tanshinone IIA attenuates the stemness of breast cancer cells viatargeting the miR-125b/STARD13 axis, Experimental Hematology & Oncology, 2022, 11(1): 2-17. (共同一作，中科院一区，IF 13.5 )

6.Yue Yang^*, Xiaoman Li^*, Ting Wang, Qianqian Guo, Tao Xi, Lufeng Zheng. Emerging agentsthat target signaling pathways in cancer stem cells, Journal of Hematology & Oncology, 2020,13(1): 60-77. (共同一作，中科院一区，IF 40.4)